Back to Search
HOWARD EDINGTON, MD
MD
Plastic and Reconstructive Surgery Physician
NPI: 1568435592IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery Physician
Surgery
Code: 208600000X
MD027758E(PA)
Surgical Oncology Physician
Surgery — Surgical Oncology
Code: 2086X0206X
MD027758E(PA)
Plastic and Reconstructive Surgery PhysicianPrimary
Surgery — Plastic and Reconstructive Surgery
Code: 2086S0122X
MD027758E(PA)
Education
TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Class of 1981
Research & Publications (20)
Intraductal location of the sclerosing adenosis of the breast.
PMID 19507655·Bratisl Lek Listy·2009
5-case
Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
PMID 19088050·Clin Cancer Res·2008
8-other
Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.
PMID 18386001·Cancer Immunol Immunother·2008
3-trial
STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy.
PMID 18305569·J Invest Dermatol·2008
8-other
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.
PMID 18093335·J Transl Med·2007
3-trial
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.
PMID 17438101·Clin Cancer Res·2007
3-trial
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
PMID 17332298·Clin Cancer Res·2007
3-trial
SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas.
PMID 17297476·Oncogene·2007
8-other
Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features.
PMID 17024556·Ann Surg Oncol·2006
8-other
Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
PMID 16941588·J Biomed Mater Res A·2006
7-preclinical
Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.
PMID 16809739·J Clin Oncol·2006
3-trial
Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation.
PMID 16567972·Melanoma Res·2006
5-case
Laparoscopically harvested omental flap for chest wall and intrathoracic reconstruction.
PMID 15480005·Ann Plast Surg·2004
8-other
Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.
PMID 14726712·Cancer Biol Ther·2004
8-other
Fluorescence imaging analysis of upstream regulators and downstream targets of STAT3 in melanoma precursor lesions obtained from patients before and after systemic low-dose interferon-alpha treatment.
PMID 12926238·Mol Imaging·2003
8-other
Thoracoscopic internal mammary sentinel node biopsy: an animal model of a new technique.
PMID 12175975·J Surg Res·2002
7-preclinical
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.
PMID 11268289·Hum Gene Ther·2001
3-trial
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
PMID 10870051·Cancer·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4727 FRIENDSHIP AVE STE 340
PITTSBURGH, PA 15224 - Phone
- (412) 235-5830
Quick Facts
- NPI
- 1568435592
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile